Indivior Pharmaceuticals, Inc. (INDV) /
The profitability of Indivior Pharmaceuticals, Inc. over the past 4 years
Chart Indivior Pharmaceuticals, Inc.: gross profit, operating income, net income, fiscal 2022–2025 Open the chart →Indivior Pharmaceuticals, Inc. reported net income of $210M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $994M and operating income of $262M. It reported a profit in 2 of the 4 years shown, and a loss in fiscal 2022 and 2023.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $994M | $262M | $210M |
| 2024ended Dec 31, 2024 | $957M | $38M | $7M |
| 2023ended Dec 31, 2023 | $919M | -$152M | -$126M |
| 2022ended Dec 31, 2022 | $749M | -$77M | -$44M |
Fiscal years as Indivior Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Indivior Pharmaceuticals, Inc.
- The revenue of Indivior Pharmaceuticals, Inc.
- The cash flow of Indivior Pharmaceuticals, Inc.
- All of Indivior Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- LOPEGRAND CANYON EDUCATION, INC.
- CORZCore Scientific, Inc./tx
- CRVLCORVEL CORPORATION
- APLEAPPLE HOSPITALITY REIT, INC.
- KGSKodiak Gas Services, Inc.
Not investment advice. This page shows what Indivior Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.